| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |